Change 2785

Time Attribute with previous and current values
Change #2785
2010-04-29
10:46:06

create Calagator::Event 1250458622 Due Diligence 2010: Strategies that protect and enhance a company seeking funding Roll back

description nil Executive team members from a recently funded medical device company will share insight into today’s investment landscape. Intended to provide C-level technology professionals an inside look at creating a winning diligence package, the discussion will be uniquely focused on maintaining an edge while engaging investors and working the process to the advantage of the company. Specific attention will be given to planning, positioning and focus at the various stages of investment including the initial approach, management of the “due dilly” process and orchestration of a successful close. Speaker bios: Michael J. Baker Mr. Baker has 27 years of executive management experience, including merger and acquisitions with Philips Medical, Lockheed Martin and GE. He has launched multiple entrepreneurial ventures in the medical device, medical IT and clean tech industries. Among these, most notable are the original picture archiving and communications system (PACS), an award-winning through wave acoustic holography system for non-radiation breast imaging and an ultra high-efficiency electric motor for use in alternative energy applications. Over the course of his professional career in innovation, his efforts have resulted in the successful commercialization of over 40 products. Currently the CEO/President of Home Dialysis Plus (HD+), a venture-backed medical device company that is developing an innovative home dialysis system, and the Managing Partner of the Baker Group LLP, Mr. Baker has secured over $65 million on behalf of various companies over the past three years. Joe Rasmussen Mr. Rasmussen specializes in financial leadership, CFO services, restructuring, raising capital, mergers & acquisitions and emerging growth. Currently the CFO of Home Dialysis Plus, he played an integral role in raising and closing the company’s recent capital investment. During his 25 years in executive management, Mr. Rasmussen has completed mergers and acquisitions, implementing a $32.5 million asset-based acquisition financing for CalTex Industries, a $120 million manufacturer of aluminum extrusions, and merging BioTek Solutions, Inc., a growth stage manufacturer of medical instruments and biochemical reagent solutions, into Ventana Medical Systems participating in the subsequent $200 million valued IPO. He raised $2 million initial seed capital and obtained $3.5 million term-sheet commitments from venture capital firms as COO and CFO for GreyPilgrim, Inc., taking a garage-based start-up to a $2 million early stage manufacturer of industrial robotic technologies. Brenda Edin With 15 years experience in business development, Ms. Edin has proven performance in the development and implementation of integrated marketing, communication and business growth strategies. She has expertise in corporate collateral development, presentation and messaging relative to fundraising with specific experience in the medical device, clean tech and service industries. A seasoned grant writer, she has brought in over $3 million in both the non-profit and commercial sectors over the course of her career. Through her role as the Director of Business Development for Home Dialysis Plus and The Baker Group LLP, she has been a critical participant in advancing multiple emerging technology companies, raising over $65 million on their behalf. Register: http://www.oen.org Date: Tuesday, May 11th, 2010 Time: 8am – 10am Where: Portland State Business Accelerator, Mt. Hood Conference Room - 209 SW Corbett Avenue & SW Meade, Portland http://www.psba.pdx.edu/drivingdirections Parking: In PSBA lot; at no charge. Cost: Free, registration required Questions: call 503-725-2312 or email PSBA office at [email protected].
end_time nil 2010-05-11 10:00:00 -0700
id nil 1250458622
start_time nil 2010-05-11 08:00:00 -0700
title nil Due Diligence 2010: Strategies that protect and enhance a company seeking funding
url nil http://www.oen.org
venue_id nil 202390009